What the researchers compared
The review brings together 28 randomized studies, with 1,129 participants in total. Trials had to report at least one parameter related to metabolic syndrome: weight, body mass index, waist circumference, blood pressure, blood glucose, insulin or lipid profile. This total therefore does not necessarily correspond to the number of participants analyzed for each outcome.
The tDCS protocols differed in the brain areas stimulated, current intensity, number of sessions and session duration. The abstract provided does not specify the overall follow-up duration or details of accompanying interventions. It does not identify any protocol with established efficacy.
Small differences, despite statistical significance
Compared with sham stimulation, active tDCS is associated with a mean weight difference of −1.16 kg. The 95% confidence interval ranges from −2.29 to −0.02 kg, so the results remain compatible with an almost negligible effect.
For waist circumference, the mean difference is −0.67 cm, with a 95% confidence interval ranging from −1.14 to −0.19 cm. These differences are statistically significant, but their small magnitude is not enough to establish a clinically meaningful improvement.
Effects on blood glucose and blood pressure vary. The abstract does not support a conclusion that metabolic parameters improve overall, let alone that the risk of diabetes or cardiovascular disease is reduced.
Control over eating remains a hypothesis to clarify
The rationale being investigated rests partly on cognitive control and the inhibition of eating behaviors. Yet the reduction in food cravings reported in this review is not statistically significant. This proposed mechanism is therefore not a demonstrated explanation for the weight difference.
The authors call for adequately powered trials and standardized assessments to clarify the mechanisms and stimulation protocols. At this stage, these findings do not support recommending a commercial device or home use.
Limitations to keep in mind
This analysis is based solely on the PubMed abstract provided, without consulting the full text. Protocols vary, and the follow-up duration is not specified. The abstract does not detail adverse effects, the methodological quality of the trials or results by population. Funding and conflicts of interest have not been checked.
What we can take away
tDCS shows a favorable but weak signal for weight and waist circumference. Its value as an adjunctive treatment remains to be confirmed, particularly over time and for clinically meaningful outcomes.
Sources and provenance
- A systematic review and meta-analysis exploring the effects of tDCS on metabolic syndrome parameters in adults.
Source date: 2026-11-16.
Journal Article, Systematic Review · Résumé PubMed uniquement, texte intégral non consulté


